Abstract
Background
Thermal burns are the leading cause of trauma worldwide. Currently, no consensus on optimal treatment of deep partial-thickness (second-degree) burns has emerged, as reflected by the wide variability in available wound-care materials. The relative efficacies of products used for treatment of partial-thickness thermal burns remain unclear. Mesotherapy features intradermal administration of various agents, depending on burn location. In the present experimental study, we explored the efficacy of mesotherapy used to treat partial-thickness thermal burns in 50 male Wistar rats divided into five groups of equal number. No procedure was performed after infliction of thermal burns in control group (Group 1). Mesotherapy was applied with physiological saline in sham group (Group 2), glutathione, taurine, and l-carnitine were separately applied in Group 3, Group 4, and Group 5, respectively.
Materials and methods
Mesotherapeutic agents were injected intradermally into the reticular layer of the dermis using the point technique. The first course of mesotherapy was given within the first 2 h after infliction of thermal burns, and therapy was continued to day 10. On day 22, unhealed thermal burn areas were measured prior to sacrifice, and biopsies covering the total areas of burns were performed to allow of pathological evaluation.
Results
Group 3 (the glutathione group) showed the best extent of healing, followed by Group 4 (the taurine group) and Group 5 (the l-carnitine group). The healed thermal burn areas in these groups were significantly greater than those in the control and sham groups (P = 0.001). All of healing, acute and chronic inflammation, the amount of granulation tissue, the level of fibroblast maturation, the amount of collagen, the extent of re-epithelization and neovascularization, and ulcer depth were scored upon pathological examination of tissue cross-sections. The best outcomes were evident in the glutathione group, with statistical significance. Although wound healing in the l-carnitine and taurine groups was better than in the control and sham groups, the differences were not statistically significant.
Conclusion
Thus, glutathione mesotherapy was effective when used to treat partial-thickness thermal burns and may be a useful treatment option for various human burns.
Similar content being viewed by others
References
Kuyumcu M, Şen H, Özkan S. Anesthesia in Burn Injury Patients. TAF Prev Med Bull. 2011;10(3):351–60.
Griffs RW. Management of multiple casualties with burns. BMJ. 1985;291:917–8.
Zor F, Ersöz N, Külahçı Y, Kapı E, Bozkurt M. Gold standards for primary care of burn management. Dicle Med J. 2009;36(3):219–25.
Kahn SA, Patel JH, Lentz CW, et al. Firefighter Burn injures: predictable patterns influenced by Turnout Gear. J Burn Care Res. 2012;33(1):152–6.
Schwarze H, Küntsher M, Uhling C, Hierlemann H, Prantl L, Ottomann C, Hartmann B. Suprathel a new skin substitue, in the management of partial-thickness burn wounds. Ann Plast Surg. 2008;60:181–5.
Atiyeh BS, Gun SW, Hayek SN. State of the art in burn treatment. World J Surg. 2005;29:131–48.
Haik J, Ashkenazy O, Sinai S, et al. Burn care standards in israel: lack of concensus. Burns. 2005;31:845–9.
Caruso DM, Foster KN, Hermans MHE, Rick C. Aquacel Ag in the management of partial-thickness burns: results of a clinical trial. J Burn Care Rehabil. 2004;25:89–97.
Lefbaschoff G, Steher D. Mesotherapy in the treatment of cellulite. In: Goldman MP, Balci PA, Leibaschoff G, Hexel D, Angelini F, editors. Cellulite pathophysichology and treatment. New York: Taylor & Francis Group; 2006. p. 263–86.
Rohrich RJ. Mesotherapy: what is it? Does it work? Plast Reconstr Surg. 2005;115(5):1425.
Caruso MK, Roberts AT, Bissoon L, et al. An evolution of mesotherapy solutions for inducing lipolysis and trating cellulite. J Plast Reconstruct Aesthet Surg. 2008;61(11):1321–4.
Atiyeh Bishara S, İbrahim Amir E, Dibo Saad A. Cosmetik mesotherapy: between Scientitic Cuidince. Science, fiction and lucrative busines Aesth plast Surg. 2008;32:842–9.
Larizzo M, De Padava MP, Tosti A. Mesotherapi in sken rejuvenation. In: Tosti A, De Padova MP, editors. Atlas of mesotherapy in skin rejuvenation. London: Informa UK Ltd; 2007. p. 1–8.
Mysore V. Mesotherapy in Management of Hairloss—Is it of Any Use? . Int J Tricholoji. 2010;2(4):45–6.
Vedamurthy M. Mesotherapy. Indian J. Dermatol Venerol Lepral. 2007;73(1):60–2.
Farriol M, Rosello J, Schwarz S. Body surface area in sprague—Dowley Rats. J Anim physial A Anim Nutr. 1997;77:61–5.
Abramov Y, Golden B, Sullivan M, Botros SM, Miller J-JR, Alshahrour A, Goldberg RP, Sand PK. Histologic characterization of vaginal vs. abdominal surgical wound healing in rabbit model. Wound Rep Reg. 2007;15:80–6.
Murray CJL, Lopez AD editors. The global burden of disease: a comprehensive assessment of mortality an disability from diseases, injuries and risk factors in 1990 and projected to 2020, vol 1. Boston, MA, USA: World Health Organization; 1996.
Yılmaz S, Sezer RE, Karagöz N, Erçöçen AR, Sezer H, et al. Sivas’ta alan taramasıyla yanık insidansının araştırılması. Türkiye Klinikleri. J Med Sci. 2010;30(5):1552–60.
Avşaroğulları L, Sözüer E, İkizceli İ, Kekeç Z, Yürümez Y, Özkan S. Adult burn injuries in an emergency department in central Anatolia, Turkey: a 5-year analysis. Burn. 2003;29:571–7.
Salmanpakoğlu N. Yanıklar ve Tedavileri. GATA Basımevi Ankara; 1998. s. 11.
Hettiaratchy S, Dziewulski P. ABC of burns. BMJ. 2004;328:1366–8.
Pistor M. What is mesotherapy? Chir dest Fr. 1976;46(288):59–60.
Rotunda AM, Kolodney MS. Mesotherapy and phosplasticdylcholtne injections: historical claritication and review. Dermatol Surg. 2006;32(4):465–80.
Meskes CJ, Laoussadi S, Kac-Ohana N, Laseire O. Contralled trial of injektable diclotenal in mesotherapy fort he treatment of tendinitis. Rev Rhum Mal osteoartic. 1990;57(7):589–91.
Aurust SD, Thomas CE, Morehouse LA, Saito M, Bucher JR. Active oxygen and toxicity. Adv Exp Med Biol. 1986;197:513–26.
Şener G, Şehirli AO, Şatıroğlu H, Keyer-Uysal M, Yeğen C. Melatonin improves oxidative organ damage in a rat model of thermal injury. Burns. 2002;28:419–25.
Şehirli AO, Şener G, Şatıroğlu H, Ayanoğlu-Dülger G. Protective effect of N-acetylcysteine on renal ischemia/reperfüsyon injury in rat. J Nephrol. 2003;16:75–8.
Arrigo AP. Gene expression and the thiol redox state. Free Radic Biol Med. 1999;27:936–44.
Youn YK, Suh GJ, Jung SE, Oh SK, Demling R. Recombinant human growth hormone decreases lung and liver tissue lipid peroxidation and increases antioxsidant activity after thermal injury in rats. J Burn Care Rehabil. 1998;19:548.
Youn YK, LaLonde C, Demling R. Oxidant and the pathophysiology of burn and smoke inhalation injury. Free Radic Biol Med. 1992;12:409–15.
Nguyen TT, Cox CS, Traber DL, Gasser H, Redl H, Schlag G, et al. Free radical activity and loss of plasma antioxidants, vitamin E and sulfhydryl groups in patients with burns: the 1993 Moyer Award. J Burn Care Rehabil. 1993;14:602–9.
LaLonde C, Nayak U, Hennigan J, Demling RH. Excessive liver oxidant stress causes mortality in response to burn injury combined with endotoxin and is prevented with antioxidants. J Burn Care Rehabil. 1997;18:187–92.
Parihar A, Parihar MS, Milner S, Bhat S. Oxidative stres and antioxidative mobilization in burn injury. Burns. 2008;34:6–17.
Militante J, Lombardini JB. Age related retinal degeneration in animal models of aging: possible involuement of tourine deficiency and oxidative stress. Neurochem Res. 1996;29(1):84–6.
Militante JD, Lombardini JB. Treatment of hypertension with oral tourine: experimental and clinical studies. Amino Acids. 2002;23(4):381–93.
Knoll B. Bildatlas der ästhetischen Mesotherapie wirkstoffe/dosierung/Anwendung. Berlin: KVM; 2010. p. 3–4.
Kargı E, Deren O, Babucçu O, Hoşnuter M, Erdoğan B. Dual synergistic effect: the effect of dexamethasone plus carnitine on skin flap survival. Ann Plast Surg. 2004;53:488–91.
Deveci M, Öztürk S, Bayram Y, Aydın A, Eken A, Şengezer M. Diyabetik yaraların tedavisinde topikal glutatyon uygulaması. Turk Plast Surg. 2005;13(3):179–84.
Vaalamo M, Leivo T, Saarialho-Kere U. Differential expression of tissueinhibitors of metalloproteinases (TIMP-1, -2, -3, and -4) in normal and aberrant wound healing. Hum Pathol. 1999;30:795–802.
Vaalamo M, Mattila L, Iohansson N, et al. Distinct populations of stromal cells express collagenase-3 (MMP-13) and collagenase-1 (MMP-1) in chronic ulcers but not in normally healing wounds. J Invest Dermatol. 1997;109:96–101.
Grinell F, Zhu M. Fibronectin degradation in chronic wounds dependson the relative levels of elastase, alpha1-proteinase inhibitor, and alpha2-macroglobulin. J Invest Dermatol. 1996;106:335–41.
Shandall AA, Williams GT, Hallet MB, et al. Colonic healing: a role for polymorphonuclear leucocytes and oxygen radical production. Br J Surg. 1986;73:225–8.
Mallya SK, Mookhtiar KA, Gao Y, et al. Characterization of 58-kilodalton human neutrophil collagenase: comparison with human fibroblast collagenase. Biochemistry. 1990;29:10628–34.
Punch J, Rees RS, Cashmer B, et al. Xanthine oxidase: its role in no-reflow phenomenon. Surgery. 1992;111:169–76.
Wilkens EW, Rees R, Smith D, et al. Identification of xanthine oxidase activity following reperfusion in human tissue. Ann Plast Surg. 1993;31:60–5.
Upadhya GA, Strasberg SM. Glutathione, lactobionate, and histidine: cryptic inhibitors of matrix metalloproteinases contained in University of Wisconsin and histidine/tryptophan/ketoglutarate liver preservation solutions. Hepatology. 2000;31:1115–22.
Kopal C, Deveci M, Ozturk S, Sengezer M. Effects of topical glutathione treatment in rat ischemic wound model. Ann Plast Surg. 2007;58(4):449–55.
Tintinalli JE. Emergency Medicine. A Comprehensive Study Guide (Emergency Medicine (Tintinalli)). New York: McGraw-Hill Companies; 2010. p. 1374–86.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors Ayhan Buz, Tahsin Görgülü, Abdulkerim Olgun, and Eksal Kargi declare that they have no conflict of interest.
Compliance with ethical requirements
The study was approved by the Animal Experiments Local Ethical Committee of the Bulent Ecevit University prior to initiation, and appropriate protocols were followed. The research was conducted in the experimental laboratory of the Medical Faculty of Bulent Ecevit University. All experimental protocols conformed to international regulations and declarations relevant to animal experimentation. Ethical Committee Approval Number: 2010-15-27/05.
Rights and permissions
About this article
Cite this article
Buz, A., Görgülü, T., Olgun, A. et al. Efficacy of glutathione mesotherapy in burns: an experimental study. Eur J Trauma Emerg Surg 42, 775–783 (2016). https://doi.org/10.1007/s00068-015-0607-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00068-015-0607-8